Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : 2002 Canadian Stock-Picking Challenge -- Ignore unavailable to you. Want to Upgrade?

To: russet who wrote (442)	3/5/2002 4:39:49 AM
From: Al Collard	Respond to of 1590

Hi russett, You had: $15,212.00 cash You bought: ONC-t @$2.85 for 5,337 shares = $15,210.45 Good luck with your new pick, Al

To: russet who wrote (442)	3/5/2002 9:22:30 AM
From: geoffb_si	Read Replies (1) \| Respond to of 1590

Russett: These "Hail Mary's" are the only way anyone in our desperate situation is going to be able to catch Marcos! Congrats to Marcos for his fine stock-picking these first 2 months. Don't look over your shoulder, Marcos...someone might be gaining on you! Geoff

To: russet who wrote (442)	3/21/2002 8:38:44 AM
From: Al Collard	Respond to of 1590

ONC-t...in the news: Oncolytics Biotech Inc. Announces REOLYSIN(R) Phase I Clinical Trial Results newswire.ca

To: russet who wrote (442)	3/26/2002 8:48:28 AM
From: Al Collard	Read Replies (1) \| Respond to of 1590

ONC-t...in the news: Animal Model Study Demonstrated Reovirus as an Effective Treatment for Breast Cancer newswire.ca

To: russet who wrote (442)	4/11/2002 11:22:20 AM
From: Al Collard	Respond to of 1590

ONC-t...in the news: Oncolytics Biotech Inc. Receives Approval To Initiate Canadian Phase I/II Brain Cancer Trial newswire.ca